Deltex Medical Group plc

DTXMF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$1,797-$1,282-$1,146-$978
Dep. & Amort.$239$133$128$114
Deferred Tax$0$0-$120-$129
Stock-Based Comp.$18$0$125$95
Change in WC$33-$232$208$434
Other Non-Cash$1,026$186$199$173
Operating Cash Flow-$481-$1,195-$606-$291
Investing Activities
PP&E Inv.-$9-$9-$744-$644
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$11-$361-$674-$621
Investing Cash Flow-$20-$370-$744-$644
Financing Activities
Debt Repay.-$58$144$233-$41
Stock Issued$0$1,887$1,340$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$109-$245-$160$543
Financing Cash Flow$51$1,786$1,413$502
Forex Effect-$13$13-$5-$7
Net Chg. in Cash-$463$234$58-$440
Supplemental Information
Beg. Cash$705$471$413$853
End Cash$242$705$471$413
Free Cash Flow-$490-$1,565-$1,350-$935
Deltex Medical Group plc (DTXMF) Financial Statements & Key Stats | AlphaPilot